✦ LIBER ✦

Ibrutinib for B cell malignancies

✍ Scribed by Novero, Aileen; Ravella, Pavan M; Chen, Yamei; Dous, George; Liu, Delong

Book ID: 121556097
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 238 KB
Volume: 3
Category: Article
ISSN: 2162-3619
DOI: 10.1186/2162-3619-3-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Positive results for ibrutinib in B-cell

Positive results for ibrutinib in B-cell malignancies

✍ Kathryn Senior 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 73 KB

Ibrutinib in chronic lymphocytic leukemi

Ibrutinib in chronic lymphocytic leukemia and B cell malignancies

✍ Brown, Jennifer R. 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 210 KB

Ibrutinib in B-cell Lymphomas

✍ Maddocks, Kami; Blum, Kristie A. 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 185 KB

Ibrutinib and Indolent B-Cell Lymphomas

✍ Akinleye, Akintunde; Furqan, Muhammad; Adekunle, Oluwaseyi 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 550 KB

Obinutuzumab for B-cell malignancies

✍ Owen, Carolyn J; Stewart, Douglas A 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 300 KB

Bruton Tyrosine Kinase Inhibitor Ibrutin

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies

✍ Advani, R. H.; Buggy, J. J.; Sharman, J. P.; Smith, S. M.; Boyd, T. E.; Grant, B 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 353 KB